What should you know about targeted next generation sequencing?

Instead of reading all genetic material, a targeted panel focuses on a chosen group of genes or regions. A sample may come from blood, saliva, a tumour or another tissue, depending on the question. In cancer care, genomic tumour profiling can help identify changes in cancer cells; other panels may examine inherited variants or pregnancy-related genetic information.

A result may be reported as a finding that is relevant, uncertain or not detected. A result cannot answer every health question and may need interpretation alongside symptoms, family history, scans or other laboratory tests. Some findings can have implications for relatives, while tumour-only findings may not be inherited.

Ask what sample will be used, which genes are included and what the test can and cannot detect. Check whether genetic counselling is available, especially when inherited risk is being considered. Ask how results are stored, who can access them and whether another sample could be needed. Keep the written report so it can be reviewed if your care changes.

Sequencing itself does not usually cause symptoms, but the reason for testing may require prompt care. Contact your clinician for new severe symptoms, rapidly worsening illness or concerns about a treatment decision while waiting for results. Seek urgent help for collapse, severe breathing difficulty, sudden weakness or confusion. Do not delay emergency care for a pending genetic report.

Is this test examining tumour changes or inherited variants? What genes are included? Could the result affect treatment or relatives? Who will explain uncertain findings, and when should I expect the report?